U.S. Semiconductors Stock News

Why Athena’s launch matters for Zeta Global Holdings (ZETA) shareholders Zeta Global Holdings (ZETA) has moved Athena by Zeta into general availability, giving enterprise marketing teams a conversational AI agent that ties predictive recommendations directly to execution and built-in financial accountability. The launch brings Athena’s Insights and Advisor apps into the Zeta Marketing Platform, offering predictive analytics, workflow automation, and ROI focused guidance across paid, owned,...

Klaviyo (KVYO) has drawn fresh attention after unveiling Composer, an AI driven tool that builds full marketing campaigns from a single prompt, along with expanded Customer Agent skills and more than 75 platform updates. See our latest analysis for Klaviyo. The AI product announcements arrive after a mixed stretch for the stock, with a 1 month share price return of 8.96% but a 90 day share price return showing a 41.9% decline and a 1 year total shareholder return showing a 37.31% decline,...

If you are wondering whether Primoris Services at around US$134 per share still offers value after a strong run, the key is to separate price excitement from what the business might actually be worth. The stock shows a 134.8% return over the last year and a very large 3 year return, even though the last 7 days and 30 days reflect declines of 5.7% and 10.8% respectively, and the year to date return sits at 2.9%. Recent coverage has focused on Primoris Services as a construction and...

For investors considering whether Restaurant Brands International at around US$73.76 represents fair value or a potential opportunity, this article focuses on what the current share price implies. The stock has declined 1.7% over the last 7 days, with returns of 2.9% over 30 days, 8.8% year to date, 14.8% over 1 year, 20.9% over 3 years, and 34.0% over 5 years. These figures can influence how investors think about both potential upside and risk. Recent news coverage has largely focused on...

Hims & Hers Health (NYSE:HIMS) has launched access to Novo Nordisk FDA-approved GLP-1 medications for eligible patients. The offering includes a range of GLP-1 options, including the only pill currently approved for weight loss. The company also introduced a new weight loss membership that combines medication access with broader support services. Hims & Hers Health focuses on telehealth and subscription based care, and GLP-1 weight loss treatments have become a key area of interest for both...

Wondering if Cactus at around US$46.70 is priced attractively or already reflects its strengths? This article walks through the key signals that matter for valuation-focused investors. The stock has seen a 2.2% decline over the last week and a 13.5% decline over the last month, while still showing returns of 3.2% over 1 year, 11.4% over 3 years and 58.7% over 5 years. These moves sit against a backdrop where investors are watching sector-wide sentiment and company-specific developments...

Fermi has yet to secure a cornerstone tenant for its flagship Project Matador campus, despite progressing permits that target 17 GW of power capacity. The company has made substantial capital commitments and lined up equipment financing, but no anchor customer contract has been confirmed. This gap between infrastructure build out and tenant sign on is raising questions about future revenue visibility and the private grid model. For investors watching NasdaqGS:FRMI, the lack of an anchor...

Commercial Metals increased its regular quarterly dividend for the 246th consecutive quarter. The latest dividend raise extends a multidecade record of uninterrupted quarterly increases. The move signals continued commitment to returning cash to shareholders. For investors watching NYSE:CMC, this dividend hike arrives with the stock trading around $60.09. The share price has seen a 31.8% gain over the past year and a 103.2% gain over the past five years, while the year-to-date return stands...

To figure out whether Tenable Holdings might still deserve a spot on your watchlist, it helps to separate emotion from price and look closely at what the current share level really implies about value. That question feels especially relevant now because the stock is trading at US$17.06, with returns of a 15.8% decline over 7 days, an 11.3% decline over 30 days, a 24.9% decline year to date, a 51.2% decline over 1 year, a 62.8% decline over 3 years, and a 54.0% decline over 5 years. Recent...

Index removal puts fresh focus on Ziff Davis Ziff Davis (ZD) has been removed from the NASDAQ Internet Index, an adjustment that can prompt portfolio shifts for index-tracking funds and encourage investors to reassess how the stock fits within internet sector exposures. See our latest analysis for Ziff Davis. The latest index exit comes after a sharp 54.8% 30 day share price return, alongside a 23.3% year to date share price gain. The 1 year total shareholder return of 11.6% contrasts with a...

Regulatory and consumer groups in Ohio are challenging American Electric Power Company's cost recovery approach for a $1.1b Grid Growth Ohio transmission project. The dispute centers on the proposed return on equity and formula rate, which opponents argue may shift data center related costs onto Ohio ratepayers without sufficient safeguards. The case is now before the Federal Energy Regulatory Commission, putting the project structure and cost allocation under closer regulatory review. For...

Todd Combs, a long-time Berkshire Hathaway investment manager and former GEICO CEO, left the conglomerate at the end of last year to run money for Jamie Dimon at JPMorgan Chase, marking a meaningful leadership shift for both firms. His departure comes as Berkshire Hathaway faces questions about its recent performance and portfolio stewardship, sharpening investor focus on succession and capital allocation decisions. We will now examine how Todd Combs’ exit and the recent performance...

Sigma Lithium (NasdaqCM:SGML) just posted its FY 2025 third quarter scorecard with revenue of US$28.5 million and a basic EPS loss of US$0.10, alongside net income excluding extra items of a US$11.6 million loss. The company has seen quarterly revenue move between US$16.9 million and US$47.7 million over the past three reported quarters, with basic EPS ranging from a profit of US$0.04 to losses of US$0.17. Trailing twelve month EPS stands at a loss of US$0.30 on revenue of US$139.0 million...

Earlier in March 2026, Casella Waste Systems, Inc. appointed Christopher A. Rains as Senior Vice President and Chief Revenue Officer, adding a leader with more than two decades of commercial, operational, and customer-focused experience across major waste management and industrial companies. Rains’ combination of industry depth, Lean Six Sigma Black Belt training, and proven work on complex organizational transformations introduces fresh commercial leadership that could influence how Casella...

In March 2026, Protagonist Therapeutics reported one-year Phase 3 data for ICOTYDE (icotrokinra) in moderate to severe plaque psoriasis, showing sustained skin clearance and a favorable safety profile as the first oral IL-23 receptor–targeted peptide. The data, including adolescent results through Week 52, underline ICOTYDE’s potential as a once-daily pill alternative to injectable treatments and highlight the company’s peptide discovery platform. We’ll now look at how ICOTYDE’s...

Event context and recent price performance Biglari Holdings (BH.A) recently caught investor attention after a 3% move in the latest session, contrasting with a decline of about 17% over the past month and a smaller pullback over the past 3 months. See our latest analysis for Biglari Holdings. That recent 3% daily share price move sits against a weaker short term trend, with a 30 day share price return of about a 17% decline. However, the 1 year total shareholder return of 50.73% and 5 year...

At the March 12, 2026 BofA Securities Information & Business Services Conference, First Advantage Corporation highlighted 17% fourth-quarter revenue growth, a transition toward capital risk management solutions, and board approval of a US$100,000,000 share repurchase program. The company’s emphasis on expanding beyond background screening into a broader capital risk management platform, supported by about 97% client retention, underlines management’s confidence in scaling the business...

Relay Therapeutics (RLAY) is back in focus after releasing new Phase 1/2 ReDiscover trial data for zovegalisib plus fulvestrant in PI3Ka-mutated, HR+/HER2- metastatic breast cancer, supporting its selected Phase 3 dosing regimen. See our latest analysis for Relay Therapeutics. The latest trial update comes after a sharp move in the stock, with a 1 day share price return of negative 5.14% and a 30 day share price return of negative 6.43%. However, a 1 year total shareholder return of 266.41%...

With no single headline event driving Allegion (ALLE) into focus, investors are instead looking at the stock's recent performance and fundamentals, including its US$4,067.3m in revenue and US$643.8m in net income. See our latest analysis for Allegion. Allegion’s recent share price performance has been soft, with a 1-month share price return of 10.33% and a year to date share price return of 10.2%. The 1-year total shareholder return sits at 12.27%, which hints at longer term holders faring...

Global Partners (GLP) has drawn investor attention after its recent share moves, with the stock closing at US$44.37. That price appears alongside mixed recent returns and a value score of 3. See our latest analysis for Global Partners. The recent pullback, with a 1-day share price return of 1.40% decline and a 7-day share price return of 4.42% decline, contrasts with a 90-day share price return of 3.98% and multi year total shareholder returns that remain strongly positive. This points to...

On March 23, Sensient Food Colors, a division of Sensient Technologies, marked the start of “Project Prism,” a major expansion of its largest natural color plant in St. Louis, Missouri, as part of a planned US$250 million program to grow capacity, supply chain and workforce. This expansion underlines how Sensient is committing significant long-term capital to meet rising demand for natural food colors as brands move away from artificial additives. Next, we’ll examine how Project Prism’s...

Arcellx (ACLX) has drawn attention after fresh performance data on its lead cancer immunotherapies prompted investors to reassess both the company’s clinical pipeline and its recent share price strength over the past 3 months. See our latest analysis for Arcellx. Over the past year Arcellx’s share price return of 80.88% year to date and 80.14% over 90 days, compared with a 74.65% one year total shareholder return and 290.09% three year total shareholder return, points to strong momentum...

What Gevo’s North Dakota expansion announcement means for the stock Gevo (GEVO) has attracted fresh attention after outlining plans to potentially add a second low carbon ethanol plant at its North Dakota site. This would more than double the current nameplate capacity. See our latest analysis for Gevo. The expansion news arrives after a strong run in the shares, with a 30 day share price return of 38.46% and a year to date share price return of 22.33%, while the 1 year total shareholder...

Universal Health Services share performance and recent context Universal Health Services (UHS) has drawn attention after a period of weaker share performance, with the stock showing a return of about negative 18% over the past 3 months and negative 11% over the past month. For investors tracking longer horizons, UHS shows a negative year to date return of roughly 16% and a modest negative total return over the past year, while the 3 year and 5 year total returns remain positive. See our...